• Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$3.09
▼ -0.07 (-2.22%)

This chart shows the closing price for YI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New 111 Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for YI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for YI

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for 111 in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $3.09.

This chart shows the closing price for YI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in 111. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/7/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/5/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/3/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/4/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/2/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/31/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/30/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/29/2023

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/8/2018JPMorgan Chase & Co.Initiated CoverageOverweight ➝ OverweightHigh
(Data available from 1/29/2018 forward)

News Sentiment Rating

1.43 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/3/2022
  • 6 very positive mentions
  • 12 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
8/2/2022
  • 4 very positive mentions
  • 12 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
9/1/2022
  • 4 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
10/1/2022
  • 4 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 2 very negative mentions
10/31/2022
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/30/2022
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
12/30/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/29/2023

Current Sentiment

  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

111 logo
111, Inc. engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. It operates through the B2C and B2B segments. The B2C segment engages in the sale of pharmaceutical and other health and wellness products directly to consumers through 1 Drugstore and its offline pharmacies. The B2B segment includes the sale of pharmaceutical products to pharmacy customers through 1 Drug Mall. The company was founded by Gang Yu and Jun Ling Liu in May 2013 and is headquartered in Shanghai, China.
Read More

Today's Range

Now: $3.09
Low: $3.06
High: $3.20

50 Day Range

MA: $3.11
Low: $2.80
High: $3.71

52 Week Range

Now: $3.09
Low: $1.37
High: $4.00

Volume

109,571 shs

Average Volume

164,673 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.93

Frequently Asked Questions

What sell-side analysts currently cover shares of 111?

The following Wall Street research analysts have issued reports on 111 in the last twelve months:
View the latest analyst ratings for YI.

What is the current price target for 111?

0 Wall Street analysts have set twelve-month price targets for 111 in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for 111 in the next year.
View the latest price targets for YI.

What is the current consensus analyst rating for 111?

111 currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for YI.

What other companies compete with 111?

How do I contact 111's investor relations team?

111's physical mailing address is 3-5/F NO.295 ZUCHONGZHI ROAD PUDONG NEW AREA, SHANGHAI F4, 201203. The company's listed phone number is 862120536666. The official website for 111 is www.111.com.cn. Learn More about contacing 111 investor relations.